tiprankstipranks
Catheter Precision (VTAK)
NYSE MKT:VTAK

Catheter Precision (VTAK) Stock Price & Analysis

274 Followers

VTAK Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.34 - $1.55
Previous Close$0.48
Volume2.20K
Average Volume (3M)49.78K
Market Cap
$3.48M
Enterprise Value$7.12M
Total Cash (Recent Filing)$5.58M
Total Debt (Recent Filing)$9.06M
Price to Earnings (P/E)>-0.1
Beta0.42
May 13, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-45.92
Shares Outstanding7,573,403
10 Day Avg. Volume24,046
30 Day Avg. Volume49,776
Standard Deviation3.73
R-Squared0.03
Alpha0.23
Financial Highlights & Ratios
Price to Book (P/B)0.16
Price to Sales (P/S)239.70
Price to Cash Flow (P/CF)-0.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue22.69
Enterprise Value/Gross Profit-48.46
Enterprise Value/Ebitda-0.09
Forecast
Price Target Upside792.27% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1

Financials

Annual

Ownership Overview

79.99%0.44%<0.01%19.56%
79.99% Insiders
<0.01% Other Institutional Investors
19.56% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

VTAK FAQ

What was Catheter Precision’s price range in the past 12 months?
Catheter Precision lowest stock price was $0.34 and its highest was $1.55 in the past 12 months.
    What is Catheter Precision’s market cap?
    Currently, no data Available
    When is Catheter Precision’s upcoming earnings report date?
    Catheter Precision’s upcoming earnings report date is May 13, 2024 which is in 14 days.
      How were Catheter Precision’s earnings last quarter?
      Catheter Precision released its earnings results on Apr 01, 2024. The company reported -$0.13 earnings per share for the quarter, beating the consensus estimate of -$0.42 by $0.29.
        Is Catheter Precision overvalued?
        According to Wall Street analysts Catheter Precision’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Catheter Precision pay dividends?
          Catheter Precision does not currently pay dividends.
          What is Catheter Precision’s EPS estimate?
          Catheter Precision’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Catheter Precision have?
          Catheter Precision has 7,573,403 shares outstanding.
            What happened to Catheter Precision’s price movement after its last earnings report?
            Catheter Precision reported an EPS of -$0.13 in its last earnings report, beating expectations of -$0.42. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of Catheter Precision?
              Currently, no hedge funds are holding shares in VTAK
              ---

              Company Description

              Catheter Precision

              Ra Medical Systems, Inc. engages in the design, development, and commercialization of excimer lasers for the treatment of dermatologic and cardiovascular diseases. Its product, Pharos, is used for the treatment of difficult-to-treat, chronic diseases including psoriasis and vitiligo. It operates through the Dermatology and Vascular business segments. The company was founded by Dean Irwin and Melissa Burstein in 2002 and is headquartered in Carlsbad, CA.
              ---

              VTAK Stock 12 Months Forecast

              Average Price Target

              $4.10
              ▲(792.27% Upside)
              {"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"plus_tr_sans","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2":"$2","5":"$5","-1":"-$1","0.5":"$0.5","3.5":"$3.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":4.1,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n  <span style=\"color:#199ca5\">$4.10</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":4.1,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n  <span style=\"color:#828080\">$4.10</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":4.1,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n  <span style=\"color:#912767\">$4.10</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,0.5,2,3.5,5],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2023","6":"Nov<br/>2023","9":"Feb<br/>2024","12":"Apr<br/>2024","25":"Apr<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.51,0.7861538461538462,1.0623076923076922,1.3384615384615384,1.6146153846153846,1.8907692307692308,2.1669230769230765,2.443076923076923,2.7192307692307693,2.995384615384615,3.2715384615384613,3.5476923076923077,3.8238461538461532,{"y":4.1,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.51,0.7861538461538462,1.0623076923076922,1.3384615384615384,1.6146153846153846,1.8907692307692308,2.1669230769230765,2.443076923076923,2.7192307692307693,2.995384615384615,3.2715384615384613,3.5476923076923077,3.8238461538461532,{"y":4.1,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.51,0.7861538461538462,1.0623076923076922,1.3384615384615384,1.6146153846153846,1.8907692307692308,2.1669230769230765,2.443076923076923,2.7192307692307693,2.995384615384615,3.2715384615384613,3.5476923076923077,3.8238461538461532,{"y":4.1,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1.31,"date":1682899200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1.08,"date":1685577600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.92,"date":1688169600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.65,"date":1690848000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.54,"date":1693526400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.45,"date":1696118400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.44,"date":1698796800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.5,"date":1701388800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.4,"date":1704067200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.47,"date":1706745600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.5,"date":1709251200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.5,"date":1711929600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.51,"date":1712275200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
              Similar Stocks
              Company
              Price & Change
              Follow
              Medtronic
              Becton Dickinson
              Baxter International
              Intuitive Surgical

              Best Analysts Covering VTAK

              1 Year
              Jeffrey CohenLadenburg Thalmann & Co.
              1 Year Success Rate
              0/1 ratings generated profit
              0%
              1 Year Average Return
              -12.40%
              reiterated a buy rating 25 days ago
              Copying Jeffrey Cohen's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -12.40% per trade.
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis